Durvalumab (D) +/- tremelimumab (T) plus platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: characteristics of long-term survivors in the CASPIAN study

Goldman J. W., Garassino M. C., Chen Y., Hotta K., Poltoratskiy A., Hochmair M. J., ...More

ONCOLOGY RESEARCH AND TREATMENT, vol.45, no.SUPPL 3, pp.161, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 45 Issue: SUPPL 3
  • Publication Date: 2022
  • Journal Name: ONCOLOGY RESEARCH AND TREATMENT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Page Numbers: pp.161
  • Istanbul University Affiliated: No